Eiko Lifesciences Ltd vs S H Kelkar Company Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 28, 2026

Key Highlights

The Latest Trading Price of Eiko Lifesciences Ltd is ₹ 49.02 as of 27 Mar 15:30 . The P/E Ratio of Eiko Lifesciences Ltd changed from 31.1 on March 2025 to 31.1 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of S H Kelkar & Company Ltd changed from 10.9 on March 2021 to 33.6 on March 2025 . This represents a CAGR of 25.25% over 5 years The Market Cap of Eiko Lifesciences Ltd changed from ₹ 65.15 crore on March 2025 to ₹ 65.15 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of S H Kelkar & Company Ltd changed from ₹ 1579 crore on March 2021 to ₹ 2460 crore on March 2025 . This represents a CAGR of 9.27% over 5 years The revenue of Eiko Lifesciences Ltd for the Dec '25 is ₹ 12.33 crore as compare to the Sep '25 revenue of ₹ 11.97 crore. This represent the growth of 3.01% The revenue of S H Kelkar & Company Ltd for the Dec '25 is ₹ 617.99 crore as compare to the Sep '25 revenue of ₹ 554.95 crore. This represent the growth of 11.36% The ebitda of Eiko Lifesciences Ltd for the Dec '25 is ₹ 2.22 crore as compare to the Sep '25 ebitda of ₹ 2.07 crore. This represent the growth of 7.25% The ebitda of S H Kelkar & Company Ltd for the Dec '25 is ₹ 89.53 crore as compare to the Sep '25 ebitda of ₹ 53.45 crore. This represent the growth of 67.5% The net profit of Eiko Lifesciences Ltd changed from ₹ 0.35 crore to ₹ 1.43 crore over 7 quarters. This represents a CAGR of 123.51% The net profit of S H Kelkar & Company Ltd changed from ₹ -86.82 crore to ₹ 32.63 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Eiko Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of S H Kelkar & Company Ltd changed from 31.03 % on March 2021 to -102 % on March 2025 . This represents a CAGR of NaN% over 5 years .

About Eiko Lifesciences Ltd

Eiko Lifesciences Limited was originally incorporated on January 07, 1977, under the name Narendra Investments (Delhi) Limited.
Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from June 24, 2021.
Earlier, the Company engaged in sale and purchase of shares and securities.
At present, the Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally. The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India.

About S H Kelkar & Company Ltd

S H Kelkar & Company Limited was incorporated on July 1, 1955 in Mumbai.
After incorporation, the Company took over businesses carried on by Mr. V.G. Vaze as a sole proprietor of M/s S.H. Kelkar & Co and in partnership by the Firm 'M/s Saraswati Chemical Works'. The Company is engaged into manufacture, supply and exports of fragrances and aroma ingredients used in the food, beverage, personal care or household product industries.
The Company has a diverse and large client base including leading national and multinational FMCG companies, blenders of fragrances & flavours and fragrance & flavour producers. The Company operate 2 business segments, fragrance and flavours segment and also has global ingredients business segment.
The Company's strength is its capability to provide innovative and customised products created by the proficient team of specialised perfumers at the creative development centres in India, Singapore and Europe.

FAQs for the comparison of Eiko Lifesciences Ltd and S H Kelkar & Company Ltd

Which company has a larger market capitalization, Eiko Lifesciences Ltd or S H Kelkar & Company Ltd?

Market cap of Eiko Lifesciences Ltd is 70 Cr while Market cap of S H Kelkar & Company Ltd is 1,653 Cr

What are the key factors driving the stock performance of Eiko Lifesciences Ltd and S H Kelkar & Company Ltd?

The stock performance of Eiko Lifesciences Ltd and S H Kelkar & Company Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Eiko Lifesciences Ltd and S H Kelkar & Company Ltd?

As of March 28, 2026, the Eiko Lifesciences Ltd stock price is INR ₹49.02. On the other hand, S H Kelkar & Company Ltd stock price is INR ₹119.45.

How do dividend payouts of Eiko Lifesciences Ltd and S H Kelkar & Company Ltd compare?

To compare the dividend payouts of Eiko Lifesciences Ltd and S H Kelkar & Company Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.